Aberdeen Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Buy |
65,858
+2,752
| +4% | +$602K | 0.02% | 505 |
|
|
2025
Q1 | $14M | Sell |
63,106
-106,834
| -63% | -$23.7M | 0.03% | 481 |
|
|
2024
Q4 | $55.6M | Sell |
169,940
-6,525
| -4% | -$2.13M | 0.1% | 193 |
|
|
2024
Q3 | $53.1M | Sell |
176,465
-11,626
| -6% | -$3.5M | 0.1% | 211 |
|
|
2024
Q2 | $62M | Sell |
188,091
-1,279
| -0.7% | -$421K | 0.12% | 177 |
|
|
2024
Q1 | $74.9M | Buy |
189,370
+7,313
| +4% | +$2.89M | 0.15% | 161 |
|
|
2023
Q4 | $64.1M | Buy |
182,057
+39,156
| +27% | +$13.8M | 0.14% | 165 |
|
|
2023
Q3 | $53.6M | Sell |
142,901
-238,243
| -63% | -$89.4M | 0.14% | 151 |
|
|
2023
Q2 | $146M | Sell |
381,144
-15,921
| -4% | -$6.09M | 0.34% | 69 |
|
|
2023
Q1 | $138M | Sell |
397,065
-11,101
| -3% | -$3.85M | 0.34% | 66 |
|
|
2022
Q4 | $96.1M | Buy |
408,166
+8,784
| +2% | +$2.07M | 0.26% | 89 |
|
|
2022
Q3 | $98.3M | Buy |
399,382
+96,232
| +32% | +$23.7M | 0.29% | 79 |
|
|
2022
Q2 | $91.1M | Buy |
303,150
+22,037
| +8% | +$6.62M | 0.29% | 81 |
|
|
2022
Q1 | $118M | Buy |
281,113
+12,775
| +5% | +$5.34M | 0.3% | 77 |
|
|
2021
Q4 | $126M | Buy |
268,338
+5,910
| +2% | +$2.77M | 0.28% | 87 |
|
|
2021
Q3 | $114M | Sell |
262,428
-3,239
| -1% | -$1.4M | 0.26% | 92 |
|
|
2021
Q2 | $95.4M | Sell |
265,667
-1,290
| -0.5% | -$463K | 0.21% | 102 |
|
|
2021
Q1 | $75.3M | Sell |
266,957
-2,877
| -1% | -$811K | 0.17% | 120 |
|
|
2020
Q4 | $76.4M | Sell |
269,834
-8,824
| -3% | -$2.5M | 0.19% | 119 |
|
|
2020
Q3 | $76.6M | Buy |
278,658
+5,066
| +2% | +$1.39M | 0.2% | 111 |
|
|
2020
Q2 | $62.2M | Buy |
273,592
+88,088
| +47% | +$20M | 0.17% | 118 |
|
|
2020
Q1 | $28.3M | Buy |
185,504
+178,123
| +2,413% | +$27.2M | 0.09% | 191 |
|
|
2019
Q4 | $1.11M | Buy |
+7,381
| New | +$1.11M | ﹤0.01% | 793 |
|